TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/26/23 17:10 | 6/22/23 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Viking Global Performance LLC | CT | T | S | -128,700 | 9.90 | 0 | -13,000 | -50 | 12,884 | I | |||||||||||||||
11/13/20 21:00 | 11/11/20 | ADPT | Adaptive Biotechnologies Corp | WA | Health | BioPrd | Biological Products, (No Diag | Viking Global Performance LLC | CT | T | S | -123,788 | 49.52 | 0 | -2,500 | -7 | 30,994 | I | |||||||||||||||
1/30/20 16:53 | 1/28/20 | ADPT | Adaptive Biotechnologies Corp | WA | Health | BioPrd | Biological Products, (No Diag | Viking Global Performance LLC | CT | T | S | -122,706 | 24.98 | 0 | -4,913 | -13 | 33,494 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |